Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05231 (
interleukin-6
)
23,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated whether day to day changes in the transport characteristics of the peritoneal membrane to macromolecules in patients treated with CAPD, were related to the levels of
interleukin-6
(
IL-6
) in the effluent of an overnight dwell. Four stable CAPD patients without peritonitis collected all "nightbags" on consecutive days during 2 months for the determination of peritoneal IgG clearance. Serum samples were obtained weekly.
IL-6
was determined in the effluent on all occasions where the IgG clearance was less than mean - SD or greater than mean + SD. On these days clearances of beta 2-microglobulin,
albumin
and alpha 2-macroglobulin were determined as well, to calculate the peritoneal restriction coefficient, i.e. the slope of the power relationship between protein clearances and their free diffusion coefficient in water. This coefficient was used as a parameter of the intrinsic permeability of the membrane.
IL-6
was measured by a sensitive and specific bioassay, using the B13.29, subclone 9.9 hybridoma cell assay. Dialysate
IL-6
was measured on 43 occasions when IgG clearance was high and on 37 occasions when IgG clearance was low. In all 4 patients indirect evidence was found for local production of
IL-6
within the peritoneal cavity: mean dialysate/serum ratios were 15 to 452 times higher than could be expected when
IL-6
would enter the dialysate by diffusion only. The patient with the highest dialysate/serum ratio showed higher clearances of
albumin
, IgG and alpha 2-macroglobulin than the other 3 patients (p less than 0.001) and a lower restriction coefficient (p less than 0.001), indicating a high intrinsic permeability.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. 155 Dec 56
Kinetics of serum levels of
interleukin-6
(
IL-6
) were studied in patients with acute Plasmodium falciparum malaria in relation to vitamin A and its binding proteins, retinol binding protein (RBP) and pre-
albumin
. It was found that
IL-6
levels followed the rise and decrease of parasitaemia by 12 hr and correlated inversely with levels of vitamin A and its binding proteins. These data suggest that vitamin A supplementation alone might still be insufficient to restore a malaria-induced vitamin A deficiency.
...
PMID:The role of interleukin-6 in vitamin A deficiency during Plasmodium falciparum malaria and possible consequences for vitamin A supplementation. 157 2
Human hepatocytes in primary culture were used as a model system to investigate the mechanism(s) involved in the induction of the acute-phase response in human liver. Hepatocytes were incubated with increasing amounts of recombinant human interleukin-1 beta, recombinant
interleukin-6
and tumor necrosis factor-alpha. Synthesis of C-reactive protein was studied at the mRNA and protein levels. Only recombinant
interleukin-6
was capable of inducing C-reactive protein-mRNA and C-reactive protein-protein synthesis. Also, fibrinogen and alpha-1-antitrypsin synthesis measured by immunoprecipitation with specific antisera increased in a dose-dependent, time-dependent manner, whereas
albumin
synthesis decreased to about 50% of controls. Maximal effects were observed at 100 to 300 units of recombinant
interleukin-6
/ml culture medium after 20 hr of incubation. Although the synthetic glucocorticoid dexamethasone slightly modulated the effect of recombinant
interleukin-6
, it was not an absolute requirement for the induction of acute-phase protein synthesis in human hepatocytes. In pulse-chase experiments it was shown that the time course of the disappearance of the acute-phase proteins from the cells and their appearance in the medium is not influenced by recombinant
interleukin-6
. This finding suggests that recombinant
interleukin-6
exerts its regulatory effect on acute-phase protein synthesis at the pretranslational level.
...
PMID:Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. 169 62
Under strict observation of the ethical guidelines of the 1975 Declaration of Helsinki Human Research Committee, primary hepatocyte cultures were prepared from second-trimester fetal liver specimens. We have shown for the first time that fetal hepatocytes have the capacity to produce an acute-phase response on treatment with inflammatory mediators. Addition of
interleukin-6
to the cultures resulted in strong induction of C-reactive protein and alpha-1-antichymotrypsin expression, whereas
albumin
expression was repressed. In contrast to
interleukin-6
, transforming growth factor-beta did not induce C-reactive protein expression. However, as in adult hepatocytes, fetal cells responded to transforming growth factor-beta by reduced
albumin
synthesis. We were able to show by virtue of fluorescein excretion into sealed clefts that fetal hepatocytes have the functional capacity to form bile. Our findings indicate that second-trimester hepatocytes can be regarded as fairly mature liver cells.
...
PMID:Human fetal hepatocytes respond to inflammatory mediators and excrete bile. 171 Oct 3
Transforming growth factor-beta (TGF beta 1), a multipotent immunoregulatory peptide produced by human platelets, has been shown to stimulate the synthesis of fibrinogen, contrapsin, complement component C3, and alpha-1-proteinase inhibitor by murine hepatocytes cultured for 2 days in DMEM containing 1 microM insulin and dexamethasone and 0.2% BSA. In the range of 10 pg to 10 ng/ml TGF-beta 1 did not elicit any change in
albumin
secretion. Two main inflammatory cytokines:
interleukin-6
(
IL-6
) and interleukin-1 (IL-1), known to stimulate two different subsets of murine acute phase plasma proteins, failed to increase contrapsin and alpha-1-proteinase inhibitor production. Epidermal growth factor (EGF) in the concentration 1 ng to 10 ng/ml effectively counteracted the stimulatory effect of TGF-beta 1 on acute phase protein production. TGF-beta 1-induced fibrinogen protein levels were associated with increased beta-fibrinogen mRNA content. TGF-beta 1 appears to be an additional physiological factor responsible for the direct stimulation of normal mouse hepatocytes to acute phase response.
...
PMID:Regulation of acute phase reaction by transforming growth factor beta in cultured murine hepatocytes. 172 35
We developed the competitive enzyme-linked immunosorbent assay for
interleukin-6
(
IL-6
). The detection limit was 30 pg per ml. Using this method, we examined the
IL-6
levels in the cerebrospinal fluid of 10 patients with multiple sclerosis (MS) and 12 age-matched normal controls.
IL-6
was detected in 6 out of 10 patients with MS. There was no significant correlation between the
IL-6
levels and other parameters, including IgG, IgG index, cell counts, total protein and
albumin
in the CSF. Our results suggest that
IL-6
detected in the MS-CSF may have no correlation to the immunological processes.
...
PMID:Interleukin-6 levels in the cerebrospinal fluid of patients with multiple sclerosis. 181 82
A prospective study of plasma and urinary
interleukin-6
(
IL-6
) levels was performed in 54 patients undergoing renal biopsy to determine whether detectable urinary
IL-6
was a reliable marker for mesangial proliferation.
Interleukin-6
was found in both the urine and plasma of seven patients, the urine alone of 15 patients, and the plasma alone of two patients.
Interleukin-6
was not detected in the urine or the plasma of the remaining 30 patients, the urine of 10 healthy controls or the urine of 10 patients with rheumatoid arthritis with raised plasma
IL-6
.
Interleukin-6
was found in the urine of only one out of an additional seven patients with lupus nephritis. Urinary
IL-6
was associated with a variety of renal abnormalities and was not restricted to those with mesangial hypercellularity. Furthermore, many patients with mesangial hypercellularity did not have detectable urinary
IL-6
. There was no correlation between urinary
IL-6
and plasma
IL-6
, urinary
albumin
excretion or urinary creatinine. These results suggest that
IL-6
detected in the urine is a marker of renal
IL-6
production, but not specifically of mesangial hypercellularity. The patients with
IL-6
in the urine had a mean serum creatinine significantly higher than those without
IL-6
. It is not possible to distinguish at present whether
IL-6
contributes to renal dysfunction or whether it reflects renal damage.
...
PMID:Urinary IL-6: a marker for mesangial proliferative glomerulonephritis? 191 27
Synovial fluids (SF) and sera (S) from patients with rheumatoid arthritis (RA) were examined for IgM, IgM-rheumatoid factor (IgM-RF),
albumin
and
interleukin-6
(
IL-6
) activity. The quotient of SF/S IgM-RF was elevated compared with that of SF/S
albumin
in 7 patients with seropositive RA, although the quotient of SF/S IgM was lower than that of SF/S
albumin
. SF
IL-6
activity was much higher than serum
IL-6
activity in all the 7 RA patients. In synovial fluids from 22 seropositive RA patients, SF
IL-6
activity was significantly correlated with the SF IgM-RF, IgG-RF and IgA- less than RF, but not with SF IgM, IgG or IgA. Moreover, SF IgM-RF as well as SF
IL-6
activity was significantly correlated with the Westergren erythrocyte sedimentation rate (ESR) or the Lansbury articular index. These results indicate that
IL-6
and RF might be produced within the rheumatoid joints as a result of abnormal immune system activation, which is associated with the disease activity of RA. Three of the 4 seronegative RA patients, however, showed high SF
IL-6
without detectable levels of SF IgM-RF, indicating that
IL-6
alone is not sufficient for IgM-RF production.
...
PMID:Correlation between rheumatoid factor and IL-6 activity in synovial fluids from patients with rheumatoid arthritis. 193 84
Bronchoalveolar lavage fluid (BALF) from subjects with a variety of interstitial lung diseases (active sarcoidosis, pigeon breeders' disease (PBD), asymptomatic pigeon breeders, patients with idiopathic pulmonary fibrosis) and from control subjects were assayed for
interleukin-6
(
IL-6
) using a novel radioimmunoassay system.
IL-6
was detectable in BALF from all groups, with disease groups showing significantly increased
IL-6
levels compared with controls (P less than 0.01 in all cases). When these results were standardized, using urea to compensate for dilution effects in the BALF, only the asymptomatic pigeon breeders had significantly higher
IL-6
levels than the controls (P less than 0.025), with all other groups showing no difference. When
albumin
was used for standardization, both the PBD group (P less than 0.001) and the sarcoidosis patients (P less than 0.01) had considerably lower levels of
IL-6
than the control subjects. Using either
albumin
or urea for standardization, the PBD patients had significantly lower levels of
IL-6
than do their asymptomatic counterparts (P less than 0.001 in both cases). This is contrasted by the finding of greatly elevated levels of IgG in the BALF of the PBD patients compared with asymptomatics (P less than 0.001). There was, however, no relation between
IL-6
and IgG in any patient group, although the PBD patients had the lowest
IL-6
and highest IgG as a group. These findings may suggest a mechanism by which asymptomatic subjects remain free from clinical complaints.
...
PMID:Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung disease and control subjects. 198 28
We have undertaken cellular and biochemical examination of bronchoalveolar lavage fluid from nonallergic patients with asthma to determine the nature and degree of inflammatory process in symptomatic asthma. Six patients with asthma (mean methacholine provocative concentration causing a 20% fall in FEV1 was 0.26 mg/ml) and six control subjects underwent fiberoptic bronchoscopy with bronchoalveolar wash. The patients with asthma shed a higher number of epithelial cells into lavage fluid than normal control subjects (p less than 0.05). Their lavage fluid also contained increased numbers of neutrophils (p less than 0.025), eosinophils (p less than 0.025), and basophilic cells (p less than 0.025), and increased proportion of activated T cells (p less than 0.05). The basophilic cells were mast cells, as indicated by positive labeling with the monoclonal antibody MCG35. Biochemical analysis of lavage fluid demonstrated exudation of protein molecules in airways of patients with asthma with increased contents of
albumin
(p less than 0.05) and fibronectin (p less than 0.05). In the lavage fluid of patients with asthma, there were also increased amounts of interleukin-1-beta (IL-1-beta) (p less than 0.025),
interleukin-6
(
IL-6
) (p less than 0.025), and granulocyte-macrophage, colony-stimulating factor (GM-CSF) (p less than 0.05), as compared with lavage fluid of normal control subjects. Immunocytochemical evaluation of lavage cells demonstrated that IL-1-beta,
IL-6
, and GM-CSF were mostly produced by nonciliated epithelial cells and/or monocytes. IL-1,
IL-6
, and GM-CSF can prime granulocytes to respond to other stimuli and can promote T cell activation.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. 201 75
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>